Insider Stock Trading History of Sanders Charles A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sanders Charles A since year 2005. The trader's CIK number is 1022936. At the time of this reporting, Sanders Charles A is the Director of Biocryst Pharmaceuticals Inc . (stock ticker symbol BCRX). See this page for all insider trading activities at Biocryst Pharmaceuticals Inc .

Note that in the past SANDERS CHARLES A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sanders Charles A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-03-13 BCRX Biocryst Pharmaceuticals Inc Buy 2,000 5.22 10,430
2011-09-30 BIOD Biodel Inc Option Ex 3,937 .00 0
2011-09-01 ICGN Icagen Inc Option Ex 11,500 3.33 38,329
2011-08-10 BIOD Biodel Inc Buy 10,000 1.16 11,600
2010-05-11 BIOD Biodel Inc Buy 5,000 5.59 27,950
2010-02-08 BCRX Biocryst Pharmaceuticals Inc Buy 5,000 6.66 33,300
2009-12-17 ICGN Icagen Inc Option Ex 2,396 .50 1,198
2009-05-18 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,333 28.44 94,790
2009-05-18 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,333 10.05 33,496
2009-05-11 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,333 30.41 101,356
2009-05-11 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,333 10.05 33,496
2009-05-04 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,334 10.05 33,506
2009-05-04 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,334 30.08 100,286
2008-05-27 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,333 26.75 89,147
2008-05-27 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,333 14.20 47,328
2008-05-20 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,333 14.20 47,328
2008-05-20 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,333 27.59 91,960
2008-05-13 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,334 14.20 47,342
2008-05-13 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,334 27.21 90,731
2008-02-06 DNA Genentech Inc Option Ex 15,000 18.60 279,000
2008-02-06 DNA Genentech Inc Sale 15,000 71.06 1,065,915
2007-05-07 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 10,000 19.78 197,800
2007-05-07 VRTX Vertex Pharmaceuticals Inc / Ma Sale 10,000 30.53 305,300
2006-12-07 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2006-12-08 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 2,000 13.23 26,460
2006-12-07 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 43.97 131,910
2006-12-08 VRTX Vertex Pharmaceuticals Inc / Ma Sale 2,000 42.95 85,900
2006-12-06 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 44.71 134,130
2006-12-06 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2006-12-05 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2006-12-05 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 44.51 133,530
2006-12-04 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2006-12-04 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 44.28 132,840
2006-12-01 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2006-12-01 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 43.86 131,580
2006-11-30 VRTX Vertex Pharmaceuticals Inc / Ma Sale 3,000 44.54 133,620
2006-11-30 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 3,000 13.23 39,690
2005-08-30 BPUR Biopure Corp Buy 10,000 1.42 14,240

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sanders Charles A (Director of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.